SEC Form 4 · accession 0000904454-15-000282
CoLucid Pharmaceuticals, Inc. · CLCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jesse I Treu
Director · 10% Owner
James C Blair
10% Owner
Nicole Vitullo
10% Owner
Brian H Dovey
10% Owner
Kathleen K Schoemaker
10% Owner
Domain Partners VI, L.P.
10% Owner
Period of report
May 11, 2015
Accepted (ET)
May 11, 2015 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3,F1,F2 | May 11, 2015 | C | 2,202,233 | $0.00 | A | 2,245,902 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF1,F2,F3 | — | May 11, 2015 | C | 798,188 | D | — | — | Common Stock | 798,188 | 0 | D |
| Series B Preferred StockF1,F2,F3 | — | May 11, 2015 | C | 939,289 | D | — | — | Common Stock | 939,289 | 0 | D |
| Series C Preferred StockF1,F2,F3 | — | May 11, 2015 | C | 464,756 | D | — | — | Common Stock | 464,756 | 0 | D |
Explanation of responses
- F1The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
- F2As managing members of the sole general partner of DP VI Associates, L.P., each Reporting Owner listed below may also be deemed to indirectly beneficially own the securities of the Issuer held by DP VI Associates, L.P., as reported on a Form 4 for DP VI Associates, L.P. filed on the same date as this Form 4. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by DP VI Associates, L.P., however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein, and/or that are not actually distributed to him or her.
- F3All outstanding shares of the Issuer's preferred stock automatically converted into Common Stock upon closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date.